One and done? new study tests single-dose radiation boost for breast cancer

NCT ID NCT07590505

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 2 times

Summary

This completed phase 3 trial tested whether a single, high-dose radiation boost (6 Gy in one session) is as good as the standard 5-session boost (10 Gy total) after whole-breast radiation in 132 breast cancer patients who had breast-conserving surgery. The main goal was to see if cosmetic outcomes were similar, while also checking side effects like breast pain and fibrosis, and quality of life. If successful, this could reduce treatment burden for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Radiation therapy (ultrahypofractionated sequential boost)
What this could lead to
If it works, this could shorten radiation treatment for breast cancer patients from 5 extra sessions to just 1, while maintaining similar cosmetic results and quality of life.
What could go wrong
This is a single-center trial with only 132 participants, so results may not apply to all patients. The experimental single-dose boost might cause more side effects like breast pain or fibrosis, and it may not be as effective as the standard approach.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Ziekenhuis aan de stroom

    Antwerp, Antwerpen, 2610, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.